MetLife Investment Management’s Core Molding Technologies CMT Stock Holding History

MetLife Investment Management’s Portfolio CMT Stock Details CMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Buy	4,772 +1,693	+55%	+$33.3K	﹤0.01%	2507
2025 Q4	$61.7K	Sell	3,079 -2,264	-42%	-$43.3K	﹤0.01%	2710
2025 Q3	$110K	Hold	5,343	–	–	﹤0.01%	2614
2025 Q2	$88.6K	Buy	+5,343	New	+$84K	﹤0.01%	2610
2024 Q4	–	Sell	-4,460	Closed	-$76.8K	–	2822
2024 Q3	$76.8K	Buy	4,460 +2,529	+131%	+$44.1K	﹤0.01%	2704
2024 Q2	$30.8K	Sell	1,931 -2,199	-53%	-$40.2K	﹤0.01%	2848
2024 Q1	$78.2K	Hold	4,130	–	–	﹤0.01%	2643
2023 Q4	$76.5K	Hold	4,130	–	–	﹤0.01%	2709
2023 Q3	$118K	Hold	4,130	–	–	﹤0.01%	2497
2023 Q2	$94K	Buy	+4,130	New	+$80.2K	﹤0.01%	2716

Other funds holding CMT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

MetLife Investment Management's CMT Position: Q1 2026 in Review

MetLife Investment Management increased its Core Molding Technologies (CMT) stake by 55% in Q1 2026, buying an estimated $33.3K and bringing the position to 4,772 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2507.

MetLife Investment Management first reported a position in CMT in Q2 2023 and has held it in 10 quarters since. The position peaked at $118K in Q3 2023. 97 funds tracked by Wall St. Rank hold CMT as of Q1 2026.

MetLife Investment Management held 4,772 shares of Core Molding Technologies worth $107K as of Q1 2026.
MetLife Investment Management bought 1,693 Core Molding Technologies shares in Q1 2026, an estimated $33.3K.
Core Molding Technologies made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2507 holding.
MetLife Investment Management first reported a position in Core Molding Technologies in Q2 2023 and has held it in 10 quarters since.
MetLife Investment Management's Core Molding Technologies position peaked at $118K in Q3 2023.
97 funds tracked by Wall St. Rank held Core Molding Technologies as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.